It is becoming clear that exposures to environmental toxins, such as lead, mercury, and arsenic can cause or contribute to the development of diseases in humans. For example, some neurobehavioral and neurodegenerative disorders, such as learning deficits and Parkinsonism have been linked to elevated lead and manganese exposures in children and manganese exposures in adults, respectively. The Smith lab explores basic mechanisms underlying how toxic metal exposures contributes to cellular effects and disease.
Summary
Published articles Show More
Brain accumulation and toxicity of Mn(II) and Mn(III) exposures.
Published in Toxicological Sciences
Concern over the neurotoxic effects of chronic moderate exposures to manganese has arisen due to increased awareness of occupational exposures and to the use of methylcyclopentadienyl manganese tricarbonyl, a manganese-containing gasoline antiknock additive. Little data exist on how the oxidation state of manganese exposure affects toxicity. The ob...
Succimer chelation normalizes reactivity to reward omission and errors in lead-exposed rats.
Published in Neurotoxicology and Teratology
This study evaluated the efficacy of a 3-week course of succimer treatment to alleviate behavioral deficits in rats exposed to lead (Pb) for the first 4 weeks of life. A 3 x 2 factorial design was used: three levels of lead exposure (No Pb, Moderate, and High Pb) and two levels of chelation (succimer or vehicle). Behavioral testing was conducted fo...
Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
Published in Environmental Health Perspectives
Although succimer (Chemet, meso-2,3-dimercaptosuccinic acid, DMSA) is considered to be a safe and effective chelating agent for the treatment of lead poisoning in humans, there is concern that it may increase the gastrointestinal (GI) absorption and retention of Pb from exposures suffered concurrent with treatment. This concern is justified because...
